s-acetyl-l-glutathione human study randomized S-Acetyl-Glutathione | Xymogen Oral delivery of glutathione: antioxidant

Its early-stage work and nobodys making clinical claims yet, but the lung regeneration angle has attracted enough interest that multiple labs are now chasing it

Corrects glutathione deficiencies (associated with aging)

Deficiency can lead to macrocytic anaemia, neurological symptoms including peripheral neuropathy, cognitive changes, and fatigue

Its typically used off-label or through veterinary compounding pharmacies

In preclinical models its reported effects concentrate at or near the site of administration, where it appears to promote new vessel formation, support fibroblast activity and stabilise the local healing environment

Individual experience varies